Q5124 Injection. byooviz, 0.1 milligrams
Also known as: Byooviz injection, aflibercept-aacf
Injection of Byooviz, aflibercept-aacf biosimilar per 0.1 milligrams, a vascular endothelial growth factor inhibitor.
In Plain Language
eye injection for macular degeneration; retinal vessel blocker
Clinical Context
Used for neovascular age-related macular degeneration and other retinal vascular conditions.
RVU Information
CPT Q5124 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5124?
CPT Q5124 (Injection. byooviz, 0.1 milligrams) is a Q Codes code. Injection of Byooviz, aflibercept-aacf biosimilar per 0.1 milligrams, a vascular endothelial growth factor inhibitor.
Is Q5124 covered by insurance?
Q5124 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for neovascular age-related macular degeneration and other retinal vascular conditions.
When is CPT Q5124 used?
Used for neovascular age-related macular degeneration and other retinal vascular conditions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.